OrbusNeich Medical Group Holdings Limited
HKSE 6929.HK
OrbusNeich Medical Group Holdings Limited Price to Book Ratio (P/B) on February 03, 2025: 0.96
-
OrbusNeich Medical Group Holdings Limited 52-week high Price to Book Ratio (P/B) is 1.45 on February 23, 2024, which is 50.24% above the current Price to Book Ratio (P/B).
-
OrbusNeich Medical Group Holdings Limited 52-week low Price to Book Ratio (P/B) is 0.82 on August 05, 2024, which is -15.29% below the current Price to Book Ratio (P/B).
-
OrbusNeich Medical Group Holdings Limited average Price to Book Ratio (P/B) for the last 52 weeks is 1.10.
| Date | Price to Book Ratio (P/B) | Dividend Yield | Free Cash Flow Yield | Price to Earnings Ratio (P/E) |
|---|
Don’t Miss A Beat
| CEO | Mr. David Chien |
| IPO Date | Dec. 23, 2022 |
| Location | Hong Kong |
| Headquarters | Building 20E |
| Employees | 1,278 |
| Sector | Healthcare |
| Industries | |
OrbusNeich Medical Group Holdings Limited, an investment holding company, manufactures, trades in, sells, and markets medical devices/instruments used for the treatment of coronary and peripheral vascular diseases in Japan, Europe, the Middle East, Africa, the Asia Pacific, the People's Republic of China, and the United States. The company offers semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, coronary stents for implantation, non-compliant balloons for post-dilatation, and specialty catheters. Its product portfolio covers various treatment processes in percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. The company was founded in 2001 and is headquartered in Shatin, Hong Kong. OrbusNeich Medical Group Holdings Limited is a subsidiary of Harmony Tree Limited.
Past 5 years
StockViz Staff
February 4, 2025
Any question? Send us an email